Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis

International Journal of Cancer

Volumn 138, Issue 1, 2016, Pages 98-109

  Wangsa, Darawalee ^a,b   Chowdhury, Salim Akhter ^c,d   Ryott, Michael ^e   Gertz, E Michael ^f   Elmberger, Göran ^g   Auer, Gert ^b   Lundqvist, Elisabeth Åvall ^b,h   Küffer, Stefan ⁱ   Ströbel, Philipp ⁱ   Schäffer, Alejandro A ^f   Schwartz, Russell ^d,j   Munck Wikland, Eva ^b   Ried, Thomas ^a   Heselmeyer Haddad, Kerstin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Carnegie Mellon University   (United States)

^e Sophiahemmet Hospital   (Sweden)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^h LINKÖPING UNIVERSITY   (Sweden)

ⁱ UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^j CARNEGIE MELLON UNIVERSITY   (United States)

more..

Author keywords

FISH; genetic markers; HPV; oral tongue cancer; phylogenetic modeling

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENOMIC DNA; PROTEIN P53; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CCND1 GENE; CHROMOSOMAL INSTABILITY; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOMETRY; DISEASE ACTIVITY; DISEASE FREE SURVIVAL; DISEASE MARKER; EGFR GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; MOLECULAR PHYLOGENY; ONCOGENE; ORAL TONGUE SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; SMOKING; SURVIVAL RATE; TERC GENE; TONGUE CARCINOMA; TUMOR SUPPRESSOR GENE; WART VIRUS; YOUNG ADULT; AGED; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; MORTALITY; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PHYLOGENY; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL ANALYSIS; TONGUE TUMOR; VIROLOGY;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; DNA COPY NUMBER VARIATIONS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TONGUE NEOPLASMS; YOUNG ADULT;

EID: 84944276406     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29691     Document Type: Article

References (52)

1. Shiboski CH, Schmidt BL, Jordan RC., Tongue and tonsil carcinoma: Increasing trends in the U.S. population ages 20-44 years. Cancer 2005; 103: 1843-9.
2. Li R, Faden DL, Fakhry C, et al., Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke. Head Neck, in press.
3. Boffetta P, Hecht S, Gray N, et al., Smokeless tobacco and cancer. Lancet Oncol 2008; 9: 667-75.
4. Maasland DH, van den Brandt PA, Kremer B, et al., Alcohol consumption, cigarette smoking and the risk of subtypes of head-neck cancer: Results from the Netherlands Cohort Study. BMC Cancer 2014; 14: 187
5. Ambatipudi S, Gerstung M, Pandey M, et al., Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers. Genes Chromosomes Cancer 2012; 51: 161-73.
6. Dahlgren L, Dahlstrand HM, Lindquist D, et al., Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 2004; 112: 1015-9.
7. Uzawa N, Sonoda I, Myo K, et al., Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas. Cancer 2007; 110: 2230-9.
8. Bhattacharya A, Roy R, Snijders AM, et al., Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. Clin Cancer Res 2011; 17: 7024-34.
9. Viet CT, Schmidt BL., Understanding oral cancer in the genome era. Head Neck 2010; 32: 1246-68.
10. Soder AI, Hoare SF, Muir S, et al., Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997; 14: 1013-21.
11. Bockmuhl U, Schluns K, Schmidt S, et al., Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2002; 33: 29-35.
12. Garnis C, Campbell J, Zhang L, et al., OCGR array: An oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 2004; 40: 511-9.
13. Chowdhury SA, Shackney SE, Heselmeyer-Haddad K, et al., Phylogenetic analysis of multiprobe fluorescence in situ hybridization data from tumor cell populations. Bioinformatics 2013; 29: I189-98.
14. Chowdhury SA, Shackney SE, Heselmeyer-Haddad K, et al., Algorithms to model single gene, single chromosome, and whole genome copy number changes jointly in tumor phylogenetics. PLoS Comput Biol 2014; 10: E1003740
15. Navin N, Krasnitz A, Rodgers L, et al., Inferring tumor progression from genomic heterogeneity. Genome Res 2010; 20: 68-80.
16. Desper R, Jiang F, Kallioniemi OP, et al., Inferring tree models for oncogenesis from comparative genome hybridization data. J Comput Biol 1999; 6: 37-51.
17. Beerenwinkel N, Rahnenfuhrer J, Daumer M, et al., Learning multiple evolutionary pathways from cross-sectional data. J Comput Biol 2005; 12: 584-98.
18. Cheng YK, Beroukhim R, Levine RL, et al., A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis. PLoS Comput Biol 2012; 8: E1002337.
19. Desper R, Jiang F, Kallioniemi OP, et al., Distance-based reconstruction of tree models for oncogenesis. J Comput Biol 2000; 7: 789-803.
20. Brennan JA, Boyle JO, Koch WM, et al., Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 712-7.
21. Greene FL, American Joint Committee on Cancer., American Cancer Society. AJCC cancer staging manual, 6th ed. New York: Springer, 2002. xiv, 421 p.
22. Heselmeyer-Haddad KM, Berroa Garcia LY, et al., Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis. Am J Pathol 2014; 184: 2671-86.
23. Heselmeyer-Haddad K, Berroa Garcia LY, Bradley A, et al., Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression. Am J Pathol 2012; 181: 1807-22.
24. Therneau TM, Grambsch PM., Modeling survival data: Extending the Cox modeled. New York: Springer, 2000. xiii, 350 p.
25. Nordfors C, Vlastos A, Du J, et al., Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer. Oral Oncol 2014; 50: 491-7.
26. Wangsa D, Heselmeyer-Haddad K, Ried P, et al., Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. Am J Pathol 2009; 175: 2637-45.
27. Heah KG, Hassan MI, Huat SC., p53 Expression as a marker of microinvasion in oral squamous cell carcinoma. Asian Pac J Cancer Prev 2011; 12: 1017-22.
28. Werkmeister R, Brandt B, Joos U., Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas. Oral Oncol 2000; 36: 100-5.
29. Park SY, Gonen M, Kim HJ, et al., Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest 2010; 120: 636-44.
30. Hoglund M, Gisselsson D, Mandahl N, et al., Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes Chromosomes Cancer 2001; 31: 156-71.
31. Akervall JA, Michalides RJ, Mineta H, et al., Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997; 79: 380-9.
32. Bova RJ, Quinn DI, Nankervis JS, et al., Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999; 5: 2810-9.
33. Fujii M, Ishiguro R, Yamashita T, et al., Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue. Cancer Lett 2001; 172: 187-92.
34. Hassan NM, Tada M, Hamada J, et al., Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer. Cancer Lett 2008; 270: 108-19.
35. Kaminagakura E, Werneck da Cunha I, Soares FA, et al., CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck 2011; 33: 1413-9.
36. Michalides RJ, van Veelen NM, Kristel PM, et al., Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1997; 123: 497-502.
37. Miyamoto R, Uzawa N, Nagaoka S, et al., Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies. Cancer 2002; 95: 2152-9.
38. Myo K, Uzawa N, Miyamoto R, et al., Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity. Cancer 2005; 104: 2709-16.
39. Nakata Y, Uzawa N, Takahashi K, et al., EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas. Eur J Cancer 2011; 47: 2364-72.
40. Ogmundsdottir HM, Bjornsson J, Holbrook WP., Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. J Oral Pathol Med 2009; 38: 565-71.
41. Sathyan KM, Sailasree R, Jayasurya R, et al., Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma. J Cancer Res Clin Oncol 2006; 132: 601-9.
42. Wang L, Liu T, Nishioka M, et al., Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: Relationship between clinicopathological appearances and cell proliferation. Oral Oncol 2006; 42: 625-31.
43. Gebhart E, Ries J, Wiltfang J, et al., Genomic gain of the epidermal growth factor receptor harboring band 7p12 is part of a complex pattern of genomic imbalances in oral squamous cell carcinomas. Arch Med Res 2004; 35: 385-94.
44. Attolini CS, Michor F., Evolutionary theory of cancer. Ann N Y Acad Sci 2009; 1168: 23-51.
45. Boca SM, Kinzler KW, Velculescu VE, et al., Patient-oriented gene set analysis for cancer mutation data. Genome Biol 2010; 11: R112.
46. Hahn WC, Counter CM, Lundberg AS, et al., Creation of human tumour cells with defined genetic elements. Nature 1999; 400: 464-8.
47. Gerstung M, Eriksson N, Lin J, et al., The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One 2011; 6: E27136
48. Vandin F, Upfal E, Raphael BJ., De novo discovery of mutated driver pathways in cancer. Genome Res 2012; 22: 375-85.
49. Cerami E, Demir E, Schultz N, et al., Automated network analysis identifies core pathways in glioblastoma. PLoS One 2010; 5: E8918
50. Smeets SJ, Brakenhoff RH, Ylstra B, et al., Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis. Cell Oncol 2009; 31: 291-300.
51. Snijders AM, Schmidt BL, Fridlyand J, et al., Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 2005; 24: 4232-42.
52. Liloglou T, Scholes AG, Spandidos DA, et al., p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability. Cancer Res 1997; 57: 4070-4.